Enterovirus and Parechovirus Infections

Infectious Diseases of the Fetus and Newborn Infant

Volumn , Issue , 2011, Pages 756-799

  Cherry, James D ^a   Krogstad, Paul ^b  

^a RADY CHILDREN'S HOSPITAL   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882509130     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-6400-8.00024-9     Document Type: Chapter

References (548)

1. Bodian D., Horstmann D.M. Polioviruses 1965, Lippincott, Philadelphia.
2. Cherry J.D., Nelson D.B. Enterovirus infections: their epidemiology and pathogenesis. Clin. Pediatr. 1966, 5:659.
3. Dalldorf G., Melnick J.L. Coxsackie Viruses 1965, Lippincott, Philadelphia.
4. Kibrick S. Current status of Coxsackie and ECHO viruses in human disease. Prog. Med. Virol. 1964, 6:27.
5. Melnick J.L. Echoviruses 1965, Lippincott, Philadelphia.
6. Cherry J.D., Krogstad P. Enteroviruses and parechoviruses. Textbook of Pediatric Infectious Diseases 2009, Saunders, Philadelphia. sixth ed. R. Feigin, J.D. Cherry (Eds.).
7. Gear J.H.S., Measroch V. Coxsackievirus infections of the newborn. Prog. Med. Virol. 1973, 15:42.
8. Grist N.R., Bell E.J., Assaad F. Enteroviruses in human disease. Prog. Med. Virol. 1978, 24:114.
9. Melnick J.L. Enteroviruses 1989, Plenum Publishing, New York.
10. Morens D.M., Zweighaft R.M., Bryan J.M. Nonpolio enterovirus disease in the United States, 1971-1975. Int. J. Epidemiol. 1979, 8:49.
11. Pallansch M.A., Roos R.P. Enteroviruses: Polioviruses, Coxsackieviruses, Echoviruses, and Newer Enteroviruses 2001, Lippincott Williams & Wilkins, Philadelphia.
12. Scott T.F.M. Clinical syndromes associated with entero virus and REO virus infections. Adv Virus Res. 1961, 8:165.
13. Stanway G., Hyypiä T. Parechoviruses. J. Virol. 1999, 73:5249.
14. Wenner H.A., Behbehani A.M. Echoviruses 1968, Springer-Verlag, New York.
15. Racaniello V.R. Picornaviridae: The Viruses and Their Replication 2001, Lippincott Williams & Wilkins, Philadelphia.
16. Stanway G., Joki-Korpela P., Hyypiä T. Human parechoviruses-biology and clinical significance. Rev. Med. Virol. 2000, 10:57.
17. Melnick J.L., et al. The enteroviruses. Am. J. Public Health 1957, 47:1556.
18. Blattner R.J., Heys F.M. Role of viruses in the etiology of congenital malformations. Prog. Med. Virol. 1961, 3:311.
19. Byington C.L., et al. A polymerase chain reaction-based epidemiologic investigation of the incidence of nonpolio enteroviral infections in febrile and afebrile infants 90 days and younger. Pediatrics 1999, 103:E27.
20. Eichenwald H.F., McCracken G.H., Kindberg S.J. Virus infections of the newborn. Prog. Med. Virol. 1967, 9:35.
21. Hanshaw J.B., Dudgeon J.A. Viral Diseases of the Fetus and Newborn 1978, Saunders, Philadelphia.
22. Hardy J.B. Viral infection in pregnancy: a review. Am. J. Obstet. Gynecol. 1965, 93:1052.
23. Hardy J.B. Viruses and the fetus. Postgrad. Med. 1968, 43:156.
24. Horstmann D.M. Viral infections in pregnancy. Yale J. Biol. Med. 1969, 42:99.
25. Kaplan M.H., et al. Group B coxsackievirus infections in infants younger than three months of age: a serious childhood illness. Rev. Infect. Dis. 1983, 5:1019.
26. Kibrick S. Viral infections of the fetus and newborn. Perspect. Med. Virol. 1961, 2:140.
27. Krajden S., Middleton P.J. Enterovirus infections in the neonate. Clin. Pediatr. 1983, 22:87.
28. Modlin J.F. Perinatal echovirus infection: insights from a literature review of 61 cases of serious infection and 16 outbreaks in nurseries. Rev. Infect. Dis. 1986, 8:918.
29. Monif G.R.G. Viral Infections of the Human Fetus 1969, Macmillan, Toronto.
30. Overall J.C., Glasgow L.A. Virus infections of the fetus and newborn infant. J. Pediatr. 1970, 77:315.
31. Plotz E.J. Virus disease in pregnancy. N. Y. J. Med. 1965, 65:1239.
32. Wang S.M., et al. Fatal coxsackievirus B infection in early infancy characterized by fulminant hepatitis. J. Infect. 1998, 37:270.
33. Khetsuriani N., et al. Neonatal enterovirus infections reported to the national enterovirus surveillance system in the United States, 1983-2003. Pediatr. Infect. Dis. J. 2006, 25:889-893.
34. Verboon-Maciolek M.A., et al. Severe neonatal parechovirus infection and similarity with enterovirus infection. Pediatr. Infect. Dis. J. 2008, 27:241-245.
35. Wolthers K.C., et al. Human parechoviruses as an important viral cause of sepsislike illness and meningitis in young children. Clin. Infect. Dis. 2008, 47:358-363.
36. Paul J.R. A History of Poliomyelitis 1971, Yale University Press, New Haven, CT.
37. Horstmann D.M. The poliomyelitis story: a scientific hegira. Yale. J. Biol. Med. 1985, 58:79.
38. Melnick J.L. Portraits of viruses: the picornaviruses. Intervirology 1983, 20:61.
39. Underwood M. A Treatise on the Diseases of Children 1789, J Mathews, London. second ed.
40. Wickman I. On the epidemiology of Heine-Medin's disease. Rev. Infect. Dis. 1980, 2:319.
41. Landsteiner K., Popper E. Übertragung der Poliomyelitis acuta auf Affen. Z. Immun. Forsch. 1909, 2:377.
42. Hannaeus G. Dissertation 1735, Copenhagen.
43. Dalldorf G., Sickles G.M. An unidentified, filtrable agent isolated from the feces of children with paralysis. Science 1948, 108:61.
44. Enders J.F., Weller T.H., Robbins F.C. Cultivation of the Lansing strain of poliomyelitis virus in cultures of various human embryonic tissues. Science 1949, 109:85.
45. Centers for Disease Control and Prevention Progress toward global poliomyelitis eradication, 1985-1994. MMWR Morb. Mortal. Wkly Rep. 1995, 44:273.
46. World Health Organization Poliomyelitis Fact Sheet No. 114, Available at. http://www.who.int/mediacentre/factsheets/fs114/en/print.html.
47. Centers for Disease Control and Prevention Progress toward global eradication of poliomyelitis, 2002. MMWR Morb. Mort. Wkly Rep. 2003, 52:366.
48. Cochi S.L., et al. Commentary: the unfolding story of global poliomyelitis eradication. J. Infect. Dis. 1997, 175:S1.
49. Hull H.F., et al. Paralytic poliomyelitis: seasoned strategies, disappearing disease. Lancet 1994, 343:1331.
50. Robbins F.C., de Quadros C.A. Certification of the eradication of indigenous transmission of wild poliovirus in the Americas. J. Infect. Dis. 1997, 175:S281.
51. Abzug M.J., Loeffelholz M., Rotbart H.A. Clinical and laboratory observations. J. Pediatr. 1995, 126:447.
52. Andréoletti L., et al. Comparison of use of cerebrospinal fluid, serum, and throat swab specimens in the diagnosis of enteroviral acute neurological infection by a rapid RNA detection PCR assay. J. Clin. Microbiol. 1998, 36:589.
53. Andréoletti L., et al. Rapid detection of enterovirus in clinical specimens using PCR and microwell capture hybridization assay. J. Virol. Methods 1996, 62:1.
54. Ishiko H., et al. Molecular diagnosis of human enteroviruses by phylogeny-based classification by use of the VP4 sequence. J. Infect. Dis. 2002, 185:744.
55. Klespies S.L., et al. Detection of enterovirus from clinical specimens by spin amplification shell vial culture and monoclonal antibody assay. J. Clin. Microbiol. 1996, 34:1465.
56. Lina B., et al. Multicenter evaluation of a commercially available PCR assay for diagnosing enterovirus infection in a panel of cerebrospinal fluid specimens. J. Clin. Microbiol. 1996, 34:3002.
57. Marshall G.S., et al. Potential cost savings through rapid diagnosis of enteroviral meningitis. Pediatr. Infect. Dis. J. 1997, 16:1086.
58. Nielsen L.P., Modlin J.F., Rotbart H.A. Detection of enteroviruses by polymerase chain reaction in urine samples of patients with aseptic meningitis. Pediatr. Infect. Dis. J. 1996, 15:125.
59. Oberste M.S., et al. Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencing. J. Clin. Virol. 2003, 26:375.
60. Romero J.R., Rotbart H.A. Sequence diversity among echoviruses with different neurovirulence phenotypes. Pediatr. Res. 1993, 33:181A.
61. Rotbart H.A. Reproducibility of AMPLICOR enterovirus PCR test results. J. Clin. Microbiol. 1997, 35:3301.
62. Sawyer M.H., et al. Diagnosis of enteroviral central nervous system infection by polymerase chain reaction during a large community outbreak. Pediatr. Infect. Dis. J. 1994, 13:177.
63. Schlesinger Y., Sawyer M.H., Storch G.A. Enteroviral meningitis in infancy: potential role for polymerase chain reaction in patient management. Pediatrics 1994, 94:157.
64. Sharland M., et al. Enteroviral pharyngitis diagnosed by reverse transcriptase-polymerase chain reaction. Arch. Dis. Child. 1996, 74:462.
65. Tanel R.E., et al. Prospective comparison of culture vs genome detection for diagnosis of enteroviral meningitis in childhood. Arch. Pediatr. Adolesc. Med. 1996, 150:919.
66. Uchio E., et al. Detection of enterovirus 70 by polymerase chain reaction in acute hemorrhagic conjunctivitis. Am. J. Ophthalmol. 1996, 122:273.
67. Yerly S., et al. Rapid and sensitive detection of enteroviruses in specimens from patients with aseptic meningitis. J. Clin. Microbiol. 1996, 34:199.
68. Rotbart H.A., O'Connel J.F., McKinlay M.A. Treatment of human enterovirus infections. Antiviral. Res. 1998, 38:1.
69. Diana G.D., Pevear D.C. Antipicornavirus drugs: current status. Antivir. Chem. Chemother. 1997, 8:401.
70. Rotbart H.A., Webster A.D. Treatment of potentially life-threatening enterovirus infections with pleconaril. Clin. Infect. Dis. 2001, 32:228.
71. Desmond R.A., et al. Enteroviral meningitis: natural history and outcome of pleconaril therapy. Antimicrob. Agents Chemother. 2006, 50:2409-2414.
72. Diedrich S., Driesel G., Schreier E. Sequence comparison of echovirus type 30 isolates to other enteroviruses in the 5vr noncoding region. J. Med. Virol. 1995, 46:148.
73. Fenner F. Classification and nomenclature of viruses: second report of the International Committee on Taxonomy of Viruses. Intervirology 1976, 7:1.
74. Hyypiä T., et al. Classification of enteroviruses based on molecular and biological properties. J. Gen. Virol. 1997, 78:1.
75. Kew O.M., et al. Molecular epidemiology of polioviruses. Virology 1995, 6:401.
76. Kubo H., Iritani N., Seto Y. Molecular classification of enteroviruses not identified by neutralization tests. Emerg. Infect. Dis. 2002, 8:298.
77. Melnick J.L. Enteroviruses: polioviruses, coxsackieviruses, echoviruses and newer enteroviruses. Virology 1990, 549-605. Raven Press, New York. second ed. B.N. Fields, D.M. Knipe (Eds.).
78. Melnick J.L. My role in the discovery and classification of the enteroviruses. Annu. Rev. Microbiol. 1996, 50:1-24.
79. Melnick J.L., et al. Picornavirus group. Virology 1963, 19:114-116.
80. Melnick J.L., Wenner H.A. Enteroviruses 1969, American Public Health Association, New York.
81. Norder H., et al. Sequencing of 'untypable' enteroviruses reveals two new types, EV-77 and EV-78, within human enterovirus type B and substitutions in the BC loop of the VP1 protein for known types. J. Gen. Virol. 2003, 84:827.
82. Pöyry T., et al. Molecular analysis of coxsackievirus A16 reveals a new genetic group of enteroviruses. Virology 1994, 202:962.
83. Pöyry T., et al. Genetic and phylogenetic clustering of enteroviruses. J. Gen. Virol. 1996, 77:1699.
84. Pulli T., Koskimies P., Hyypiä T. Molecular comparison of coxsackie A virus serotypes. Virology 1995, 212:30.
85. Rueckert R.R. Picornaviridae and Their Replication 1990, Raven Press, New York.
86. Stanway G., et al. Family picornaviridae. Virus Taxonomy, Eighth Report of the International Committee on Taxonomy of Viruses 2005, 757-778. Elsevier/Academic Press, London. C.M. Fauquet (Ed.).
87. Oberste M.S., et al. Typing of human enteroviruses by partial sequencing of VP1. J. Clin. Microbiol. 1999, 37:1288-1293.
88. Oberste M.S., et al. Molecular identification of 13 new enterovirus types, EV79-88, EV97, and EV100-101, members of the species human enterovirus B. Virus. Res. 2007, 128:34-42.
89. Brown B., et al. Complete genomic sequencing shows that polioviruses and members of human enterovirus species C are closely related in the noncapsid coding region. J. Virol. 2003, 77:8973-8984.
90. Benschop K.S., et al. Widespread recombination within human parechoviruses: analysis of temporal dynamics and constraints. J. Gen. Virol. 2008, 89(Pt 4):1030-1035.
91. Chan Y.F., AbuBakar S. Recombinant human enterovirus 71 in hand, foot and mouth disease patients. Emerg. Infect. Dis. 2004, 10:1468-1470.
92. Chevaliez S., et al. Molecular comparison of echovirus 11 strains circulating in Europe during an epidemic of multisystem hemorrhagic disease of infants indicates that evolution generally occurs by recombination. Virology 2004, 325:56-70.
93. Krogstad P., et al. Fatal neonatal myocarditis caused by a recombinant human enterovirus-B variant. Pediatr. Infect. Dis. J. 2008, 27:668-669.
94. Lukashev A.N. Role of recombination in evolution of enteroviruses. Rev. Med. Virol. 2005, 15:157-167.
95. Lukashev A.N., et al. Recombination in circulating enteroviruses. J. Virol. 2003, 77:10423-10431.
96. Lukashev A.N., et al. Recombination in circulating human enterovirus B: independent evolution of structural and non-structural genome regions. J. Gen. Virol. 2005, 86(Pt. 12):3281-3290.
97. Oberste M.S., Maher K., Pallansch M.A. Evidence for frequent recombination within species human enterovirus B based on complete genomic sequences of all thirty-seven serotypes. J. Virol. 2004, 78:855-867.
98. Oberste M.S., Penaranda S., Pallansch M.A. RNA recombination plays a major role in genomic change during circulation of coxsackie B viruses. J. Virol. 2004, 78:2948-2955.
99. Badorff C., et al. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat. Med. 1999, 5:320-326.
100. Doedens J.R., Kirkegaard K. Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A. Embo. J. 1995, 14:894-907.
101. Krogerus C., et al. Replication complex of human parechovirus 1. J. Virol. 2003, 77:8512-8523.
102. Noordhoek G.T., et al. Clinical validation of a new real-time PCR assay for detection of enteroviruses and parechoviruses, and implications for diagnostic procedures. J. Clin. Virol. 2008, 41:75-80.
103. Romero J.R. Enteroviruses and parechoviruses. Manual of Clinical Microbiology 2007, 1392-1404. ASM Press, Washington, DC. nineth ed. P.R. Murray (Ed.).
104. Bryden A.S. Isolation of enteroviruses and adenoviruses in continuous simian cell lines. Med. Lab. Sci. 1992, 49:60.
105. Cherry J.D., et al. Acute hemangiomalike lesions associated with ECHO viral infections. Pediatrics 1969, 44:498.
106. Hatch M.H., Marchetti G.E. Isolation of echoviruses with human embryonic lung fibroblast cells. Appl. Microbiol. 1971, 22:736.
107. Kelen A.E., Lesiak J.M., Labzoffsky N.A. An outbreak of aseptic meningitis due to ECHO 25 virus. Can. Med. Assoc. J. 1964, 90:1349.
108. Bell E.J., Cosgrove B.P. Routine enterovirus diagnosis in a human rhabdomyosarcoma cell line. Bull. World Health Organ. 1980, 58:423.
109. Herrmann E.C. Experience in providing a viral diagnostic laboratory compatible with medical practice. Mayo Clin. Proc. 1967, 42:112.
110. Terletskaia-Ladwig E., et al. Evaluation of enterovirus serological tests IgM-EIA and complement fixation in patients with meningitis, confirmed by detection of enteroviral RNA by RT-PCR in cerebrospinal fluid. J. Med. Virol. 2000, 61:221.
111. Terletskaia-Ladwig E., et al. A new enzyme immunoassay for the detection of enteroviruses in faecal specimens. J. Med. Virol. 2000, 60:439.
112. Gelfand H.M. The occurrence in nature of the Coxsackie and ECHO viruses. Prog. Med. Virol. 1961, 3:193.
113. Cherry J.D. Enteroviruses and Parechoviruses 2003, Saunders, Philadelphia.
114. Keswick B.H., Gerba C.P., Goyal S.M. Occurrence of enteroviruses in community swimming pools. Am. J. Public Health 1981, 71:1026.
115. Johnson I., Hammond G.W., Verma M.R. Nosocomial Coxsackie B4 virus infections in two chronic-care pediatric neurological wards. J. Infect. Dis. 1985, 151:1153.
116. Maus M.V., et al. Detection of echovirus 18 in human breast milk. J. Clin. Microbiol. 2008, 46:1137-1140.
117. Chang M.L., et al. Coxsackievirus B3 in human milk. Pediatr. Infect. Dis. J. 2006, 25:955-957.
118. Downey T.W. Polioviruses and flies: studies on the epidemiology of enteroviruses in an urban area. Yale J. Biol. Med. 1963, 35:341.
119. Melnick J.L., et al. Seasonal distribution of Coxsackie viruses in urban sewage and flies. Am. J. Hyg. 1954, 59:164.
120. Melnick J.L., Dow R.P. Poliomyelitis in Hidalgo County, Texas 1948: poliomyelitis and Coxsackie viruses from flies. Am. J. Hyg. 1953, 58:288.
121. Horn P. Poliomyelitis in pregnancy: a twenty-year report from Los Angeles County, California. Obstet. Gynecol. 1955, 6:121.
122. Gresser I., Chany C., Enders J.F. Persistent polioviral infection of intact human amniotic membrane without apparent cytopathic effect. J. Bacteriol. 1965, 89:470.
123. Abramson H., Greenberg M., Magee M.C. Poliomyelitis in the newborn infant. J. Pediatr. 1953, 43:167.
124. Aycock W.L. The frequency of poliomyelitis in pregnancy. N. Engl. J. Med. 1941, 225:405.
125. Barsky P., Beale A.J. The transplacental transmission of poliomyelitis. J. Pediatr. 1957, 51:207.
126. Baskin J.L., Soule E.H., Mills S.D. Poliomyelitis of the newborn: pathologic changes in two cases. Am. J. Dis. Child. 1950, 80:10.
127. Bates T. Poliomyelitis in pregnancy, fetus, and newborn. Am. J. Dis. Child. 1955, 90:189.
128. Blattner R.J. Intrauterine infection with poliovirus, type I. J. Pediatr. 1963, 62:625.
129. Carter H.M. Congenital poliomyelitis. Obstet. Gynecol. 1956, 8:373.
130. Elliott G.B., McAllister J.E., Alberta C. Fetal poliomyelitis. Am. J. Obstet. Gynecol. 1956, 72:896.
131. Jackson A.L., Louw J.X. Poliomyelitis at birth due to transplacental infection. S. Afr. Med. J. 1959, 33:357.
132. Johnson J.F., Stimson P.M. Clinical poliomyelitis in the early neonatal period. J. Pediatr. 1956, 40:733.
133. Kreibich H., Wold W. Ueber einen Fall von diaplazenter poliomyelitis Infektion des Feten in 9 Schwangerschaftsmonat. Zentralbl. Gynaekol. 1950, 72:694.
134. Lance M. Paralysis infantile (poliomyelité) constatée des la naissance. Bull. Soc. Pediatr. (Paris) 1933, 31:2297.
135. Lycke E., Nilsson L.R. Poliomyelitis in a newborn due to intrauterine infection. Acta Paediatr. 1962, 51:661.
136. Schaeffer M., Fox M.J., Li C.P. Intrauterine poliomyelitis infection. JAMA 1954, 155:248.
137. Severin G. Case of poliomyelitis in newborn. Nord. Med. 1939, 1:55.
138. Shelokov A., Habel K. Subclinical poliomyelitis in a newborn infant due to intrauterine infection. JAMA 1956, 160:465.
139. Shelokov A., Weinstein L. Poliomyelitis in the early neonatal period: report of a case of possible intrauterine infection. J. Pediatr. 1951, 38:80.
140. Siegel M., Greenberg M. Poliomyelitis in pregnancy: effect on fetus and newborn infant. J. Pediatr. 1956, 49:280.
141. Swarts C.L., Kercher E.F. A fatal case of poliomyelitis in a newborn infant delivered by cesarean section following maternal death due to poliomyelitis. Pediatrics 1954, 14:235.
142. Wingate M.B., Meller H.K., Ormiston G. Acute bulbar poliomyelitis in late pregnancy. BMJ 1961, 1:407.
143. Winsser J., Pfaff M.L., Seanor H.E. Poliomyelitis viremia in a newborn infant. Pediatrics 1957, 20:458.
144. Wyatt H.V. Poliomyelitis in the fetus and the newborn: a comment on the new understanding of the pathogenesis. Clin. Pediatr. 1979, 18:33.
145. Pearson R.J.C., Miller D.G., Palmier M.L. Reactions to the oral vaccine. Yale J. Biol. Med. 1962, 34:498.
146. Prem K.A., et al. Vaccination of Pregnant Women and Young Infants with Trivalent Oral Attenuated Live Poliomyelitis Vaccine 1960, Pan American Sanitary Bureau, Washington, DC.
147. Prem K.A., McKelvey J.L. Immunologic Response of Pregnant Women to Oral Trivalent Poliomyelitis Vaccine 1959, Pan American Sanitary Bureau, Washington, DC.
148. Cabasso V.J., et al. Oral poliomyelitis vaccine, Lederle: thirteen years of laboratory and field investigation. N. Engl. J. Med. 1960, 263:1321.
149. Horstmann D.M. Epidemiology of poliomyelitis and allied diseases-1963. Yale J. Biol. Med. 1963, 36:5.
150. Horstmann D.M., et al. Viremia in infants vaccinated with oral poliovirus vaccine (Sabin). Am. J. Hyg. 1964, 79:47.
151. Katz S.L. Efficacy, potential and hazards of vaccines. N. Engl. J. Med. 1964, 270:884.
152. McKay H.W., Fodor A.R., Kokko U.P. Viremia following the administration of live poliovirus vaccines. Am. J. Public Health 1963, 53:274.
153. Melnick J.L., et al. Free and bound virus in serum after administration of oral poliovirus vaccine. Am. J. Epidemiol. 1966, 84:329.
154. Payne A.M.M. Summary of the Conference 1960, Pan American Sanitary Bureau, Washington, DC.
155. White L.R. Comment. Viral Etiology of Congenital Malformations, May 19-20, 1967 1968, U.S. Government Printing Office, Washington, DC.
156. Dalldorf G., Gifford R. Susceptibility of gravid mice to Coxsackie virus infection. J. Exp. Med. 1954, 99:21.
157. Berger E., Roulet F. Beitrage zur Ausscheidung und Tierpathogenitüt des Coxsackie-virus. Schweiz. Z. Allg. Pathol. 1952, 15:462.
158. Selzer G. Transplacental infection of the mouse fetus by Coxsackie viruses. Isr. J. Med. Sci. 1969, 5:125.
159. Soike K. Coxsackie B-3 virus infection in the pregnant mouse. J. Infect. Dis. 1967, 117:203.
160. Modlin J.F., Crumpacker C.S., Coxsackievirus B. infection in pregnant mice and transplacental infection of the fetus. Infect. Immun. 1982, 37:222.
161. Flamm H. Some Considerations Concerning the Pathogenesis of Prenatal Infections 1966, U.S. Government Printing Office, Washington, DC.
162. Flamm H. Untersuchungen über die diaplazentare Übertragung des Coxsackievirus. Schweiz. Z. Allg. Pathol. 1955, 18:16.
163. Palmer A.L., et al. Adverse effects of maternal enterovirus infection on the fetus and placenta. J. Infect. Dis. 1997, 176:1437.
164. Abzug M.J. Maternal factors affecting the integrity of the late gestation placental barrier to murine enterovirus infection. J. Infect. Dis. 1997, 176:41.
165. Benirschke K. Viral Infection of the Placenta 1968, U.S. Government Printing Office, Washington, DC.
166. Kibrick S., Benirschke K. Acute aseptic myocarditis and meningoencephalitis in the newborn child infected with Coxsackie virus group B, type 3. N. Engl. J. Med. 1956, 255:883.
167. Brightman V.J., et al. An outbreak of Coxsackie B-5 virus infection in a newborn nursery. J. Pediatr. 1966, 69:179.
168. Konstantinidou A., et al. Transplacental infection of coxsackievirus B3 pathological findings in the fetus. J. Med. Virol. 2007, 79:754-757.
169. Euscher E., et al. Coxsackie virus infection of the placenta associated with neurodevelopmental delays in the newborn. Obstet. Gynecol. 2001, 98:1019-1026.
170. Basso N.G.S., et al. Enterovirus isolation from foetal and placental tissues. Acta Virol. 1990, 34:49.
171. Bates H.R. Coxsackie virus B3 calcific pancarditis and hydrops fetalis. Am. J. Obstet. Gynecol. 1970, 106:629.
172. Bendig J., et al. Coxsackievirus B3 sequences in the blood of a neonate with congenital myocarditis, plus serological evidence of maternal infection. J. Med. Virol. 2003, 70:606.
173. Benirschke K., Pendleton M.E. Coxsackie virus infection: an important complication of pregnancy. Obstet. Gynecol. 1958, 12:305.
174. Cherry J.D., Soriano F., Jahn C.L. Search for perinatal viral infection: a prospective, clinical, virologic and serologic study. Am. J. Dis. Child. 1968, 116:245.
175. Hanson L., et al. Clinical and serological observations in cases of Coxsackie B3 infections in early infancy. Acta Paediatr. Scand. 1966, 55:577.
176. Makower H., Skurska Z., Halazinska L. On transplacental infection with Coxsackie virus. Texas Rep. Biol. Med. 1958, 16:346.
177. McLean D.M., et al. Coxsackie B5 virus as a cause of neonatal encephalitis and myocarditis. Can. Med. Assoc. J. 1961, 85:1046.
178. Puschak R.B. Coxsackie virus infection in the newborn with case report. Harrisburg Polyclinic Hosp. J. 1962, 14.
179. Burch G.E., et al. Interstitial and coxsackievirus B myocarditis in infants and children. JAMA 1968, 203:1.
180. Plager H., Beeve R., Miller J.K. Coxsackie B-5 pericarditis in pregnancy. Arch. Intern. Med. 1962, 110:735.
181. Euscher E., et al. Coxsackievirus virus infection of the placenta associated with neurodevelopmental delays in the newborn. Obstet. Gynecol. 2001, 98:1019.
182. Yoshioka I., Horstmann D.M. Viremia in infection due to ECHO virus type 9. N. Engl. J. Med. 1960, 262:224.
183. Kleinman H., et al. ECHO 9 virus infection and congenital abnormalities: a negative report. Pediatrics 1962, 29:261.
184. Landsman J.B., Grist N.R., Ross C.A.C. Echo 9 virus infection and congenital malformations. Br. J. Prev. Soc. Med. 1964, 18:152.
185. Rantasalo I., et al. ECHO 9 virus antibody status after an epidemic period and the possible teratogenic effect of the infection. Ann. Paediatr. Fenn. 1960, 6:175.
186. Moscovici C., Maisel J. Intestinal viruses of newborn and older prematures. Am. J. Dis. Child. 1961, 101:771.
187. Eichenwald H.F., Kostevalov O. Immunologic responses of premature and full-term infants to infection with certain viruses. Pediatrics 1960, 25:829.
188. Berkovich S., Smithwick E.M. Transplacental infection due to ECHO virus type 22. J. Pediatr. 1968, 72:94.
189. Hughes J.R., et al. Echovirus 14 infection associated with fatal neonatal hepatic necrosis. Am. J. Dis. Child. 1972, 123:61.
190. Chow K., et al. Congenital enterovirus 71 infection: a case study with virology and immunochemistry. Clin. Infect. Dis. 2000, 31:509.
191. Otonkoski T., et al. Neonatal type I diabetes associated with maternal echovirus 6 infection: a case report. Diabetologia 2000, 43:1235.
192. Kleger B., et al. Herpes simplex infection of the female genital tract, I. Incidence of infection. Am. J. Obstet. Gynecol. 1968, 102:745.
193. Montgomery R., Youngblood L., Medearis D.N. Recovery of cytomegalovirus from the cervix in pregnancy. Pediatrics 1972, 49:524.
194. Reyes M.P., et al. Coxsackievirus-positive cervices in women with febrile illnesses during the third trimester in pregnancy. Am. J. Obstet. Gynecol. 1986, 155:159.
195. Reyes M.P., et al. Disseminated neonatal echovirus 11 disease following antenatal maternal infection with a virus-positive cervix and virus-negative gastrointestinal tract. J. Med. Virol. 1983, 12:155.
196. Cheng L.L., et al. Probable intrafamilial transmission of coxsackievirus b3 with vertical transmission, severe early-onset neonatal hepatitis, and prolonged viral RNA shedding. Pediatrics 2006, 118:e929-e933.
197. Cole R.M., et al. Studies of Coxsackie viruses: observations on epidemiologic aspects of group A viruses. Am. J. Public Health 1951, 41:1342.
198. Ramos-Alvarez M., Sabin A.B. Intestinal viral flora of healthy children demonstrable by monkey kidney tissue culture. Am. J. Public Health 1956, 46:295.
199. Vandeputte M. L'endémicité des virus entériques à Léopoldville, Congo. Bull. WHO/OMS 1960, 22:313.
200. Katz S.L. Case records of the Massachusetts General Hospital. Case 20-1965. N. Engl. J. Med. 1965, 272:907.
201. Jenista J.A., Powell K.R., Menegus M.A. Epidemiology of neonatal enterovirus infection. J. Pediatr. 1984, 104:685.
202. Földes P., et al. Vaccination of newborn children with live poliovirus vaccine. Acta Microbiol. Acad. Sci. Hung. 1962, 9:305.
203. Katz M., Plotkin S.A. Oral polio immunization of the newborn infant: a possible method of overcoming interference by ingested antibodies. J. Pediatr. 1968, 73:267.
204. Keller R., et al. Intestinal IgA neutralizing antibodies in newborn infants following poliovirus immunization. Pediatrics 1969, 43:330.
205. Lepow M.L., et al. Effect of Sabin type 1 poliomyelitis vaccine administered by mouth to newborn infants. N. Engl. J. Med. 1961, 264:1071.
206. Lepow M.L., et al. Sabin type 1 (LSc2ab) oral poliomyelitis vaccine. Am. J. Dis. Child. 1962, 104:67.
207. Murphy W. Response of infants to trivalent poliovirus vaccine (Sabin strains). Pediatrics 1967, 40:980.
208. Pagano J.S., Plotkin S.A., Cornely D. The response of premature infants to infection with type 3 attenuated poliovirus. J. Pediatr. 1964, 65:165.
209. Pagano J.S., et al. The response of premature infants to infection with attenuated poliovirus. Pediatrics 1962, 29:794.
210. Pagano J.S., Plotkin S.A., Koprowski H. Variations in the response of infants to living attenuated poliovirus vaccines. N. Engl. J. Med. 1961, 264:155.
211. Plotkin S.A., et al. Oral poliovirus vaccination in newborn African infants. Am. J. Dis. Child. 1966, 111:27.
212. Sabin A.B., et al. Effect of oral poliovirus vaccine in newborn children. I. Excretion of virus after ingestion of large doses of type 1 or of mixture of all three types, in relation to level of placentally transmitted antibody. Pediatrics 1963, 31:623.
213. Sabin A.B., et al. Effect of oral poliovirus vaccine in newborn children. II. Intestinal resistance and antibody response at 6 months in children fed type 1 vaccine at birth. Pediatrics 1963, 31:641.
214. Warren R.J., et al. The relationship of maternal antibody, breast feeding, and age to the susceptibility of newborn infants to infection with attenuated polioviruses. Pediatrics 1964, 34:4.
215. Bergeisen G.H., Bauman R.J., Gilmore R.L. Neonatal paralytic poliomyelitis: a case report. Arch. Neurol. 1986, 43:192.
216. Javett S.N., et al. Myocarditis in the newborn infant. J. Pediatr. 1956, 48:1.
217. Kipps A., et al. Coxsackie virus myocarditis of the newborn. Med. Proc. 1958, 4:401.
218. Archibald E., Purdham D.R. Coxsackievirus type A16 infection in a neonate. Arch. Dis. Child. 1979, 54:649.
219. Artenstein M.S., Cadigan F.C., Buescher E.L. Epidemic Coxsackie virus infection with mixed clinical manifestations. Ann. Intern. Med. 1964, 60:196.
220. Butler N., et al. Fatal Coxsackie B3 myocarditis in a newborn infant. BMJ 1962, 1:1251.
221. Cherry J.D., Jahn C.L. Virologic studies of exanthems. J. Pediatr. 1966, 68:204.
222. Cherry J.D., et al. 1962, Unpublished data.
223. Delaney T.B., Fakunaga F.H. Myocarditis in a newborn with encephalomeningitis due to Coxsackie virus group B, type 5. N. Engl. J. Med. 1958, 259:234.
224. Dömök I., Molnár E. An outbreak of meningoencephalomyocarditis among newborn infants during the epidemic of Bornholm disease of 1958 in Hungary, II. Aetiological findings. Ann. Pediatr. 1960, 194:102.
225. Farber S., Vawter G.F. Clinical pathological conference. J. Pediatr. 1963, 62:786.
226. Fechner R.E., Smith M.G., Middelkamp J.N. Coxsackie B virus infection of the newborn. Am. J. Pathol. 1963, 42:493.
227. Gear J. Coxsackie virus infections in Southern Africa. Yale J. Biol. Med. 1961, 34:289.
228. Gear J., Measroch V., Prinsloo F.R. The medical and public health importance of the Coxsackie viruses. S. Afr. Med. J. 1956, 30:806.
229. Gear J.H.S. Coxsackie virus infection of the newborn. Prog. Med. Virol. 1958, 1:106.
230. Hosier D.M., Newton W.A. Serious Coxsackie infection in infants and children. Am. J. Dis. Child. 1958, 96:251.
231. Hurley R., Norman A.P., Pryse-Davies J. Massive pulmonary hemorrhage in the newborn associated with Coxsackie B virus infection. BMJ 1969, 3:636.
232. Isacsohn M., et al. Neonatal coxsackievirus group B infections: experience of a single department of neonatology. Isr. J. Med. Sci. 1994, 30:371.
233. Jack I., Townley R.R.W. Acute myocarditis of newborn infants, due to Coxsackie viruses. Med. J. Aust. 1961, 2:265.
234. Jahn C.L., Cherry J.D. Mild neonatal illness associated with heavy enterovirus infection. N. Engl. J. Med. 1966, 274:394.
235. Jennings R.C. Coxsackie group B fatal neonatal myocarditis associated with cardiomegaly. J. Clin. Pathol. 1966, 19:325.
236. Johnson W.R. Manifestations of Coxsackie group B infections in children. Del. Med. J. 1960, 32:72.
237. Kibrick S., Benirschke K. Severe generalized disease (encephalohepatomyocarditis) occurring in the newborn period and due to infection with Coxsackie virus, group B. Pediatrics 1958, 22:857.
238. Koch V.F., Enders-Ruckle G., Wokittel E. Coxsackie B5-Infektionen mit signifikanter Antikörperentwicklung bei Neugeborenen. Arch. Kinderheilkd. 1962, 165:245.
239. Lapinleimu K., Kaski U. An outbreak caused by coxsackievirus B5 among newborn infants. Scand. J. Infect. Dis. 1972, 4:27.
240. McLean D.M., et al. Viral infections of Toronto children during 1965, I. Enteroviral disease. Can. Med. Assoc. J. 1966, 94:839.
241. Montgomery J., et al. Myocarditis of the newborn: an outbreak in a maternity home in Southern Rhodesia associated with Coxsackie group-B virus infection. S. Afr. Med. J. 1955, 29:608.
242. Moossy J., Geer J.C. Encephalomyelitis, myocarditis and adrenal cortical necrosis in Coxsackie B3 virus infection. Arch. Pathol. 1960, 70:614.
243. Nogen A.G., Lepow M.L. Enteroviral meningitis in very young infants. Pediatrics 1967, 40:617.
244. Rantakallio P., Lapinleimu K., Mäntyjärvi R. Coxsackie B5 outbreak in a newborn nursery with 17 cases of serious meningitis. Scand. J. Infect. Dis. 1970, 2:17.
245. Rapmund G., et al. Neonatal myocarditis and meningoencephalitis due to Coxsackie virus group B, type 4: virologic study of a fatal case with simultaneous aseptic meningitis in the mother. N. Engl. J. Med. 1959, 260:819.
246. Robino G., et al. Fatal neonatal infection due to Coxsackie B2 virus. J. Pediatr. 1962, 61:911.
247. Sieber O.F., et al. Immunological response of the newborn infant to Coxsackie B-4 infection. Pediatrics 1967, 40:444.
248. Suckling P.V., Vogelpoel L. Coxsackie myocarditis of the newborn. Med. Proc. 1958, 4:372.
249. Sussman M.L., Strauss L., Hodes H.L. Fatal Coxsackie group B infection in the newborn. Am. J. Dis. Child. 1959, 97:483.
250. Tuuteri L., Lapinleimu K., Meurman L. Fatal myocarditis associated with Coxsackie B3 infection in the newborn. Ann. Paediatr. Fenn. 1963, 9:56.
251. Van Creveld S., De Jager H. Myocarditis in newborns, caused by Coxsackie virus: clinical and pathological data. Ann. Pediatr. 1956, 187:100.
252. Verlinde J.D., Van Tongeren H.A.E., Kret A. Myocarditis in newborns due to group B Coxsackie virus: virus studies. Ann. Pediatr. 1956, 187:113.
253. Volakova N., Jandasek L. Epidemic of myocarditis in newborn infants caused by Coxsackie B1 virus. Cesk. Epidemiol. 1963, 13:88.
254. Winsser J., Altieri R.H. A three-year study of Coxsackie virus, group B, infection in Nassau County. Am. J. Med. Sci. 1964, 247:269.
255. Woodward T.E., et al. Viral and rickettsial causes of cardiac disease, including the Coxsackie virus etiology of pericarditis and myocarditis. Ann. Intern. Med. 1960, 53:1130.
256. Wright H.T., Okuyama K., McAllister R.M. An infant fatality associated with Coxsackie B1 virus. J. Pediatr. 1963, 63:428.
257. Swender P.T., Shott R.J., Williams M.L. A community and intensive care nursery outbreak of coxsackievirus B5 meningitis. Am. J. Dis. Child. 1974, 127:42.
258. Berkovich S., Kibrick S. ECHO 11 outbreak in newborn infants and mothers. Pediatrics 1964, 33:534.
259. Berkovich S., Pangan J. Recoveries of virus from premature infants during outbreaks of respiratory disease: the relation of ECHO virus type 22 to disease of the upper and lower respiratory tract in the premature infant. Bull. N. Y. Acad. Med. 1968, 44:377.
260. Butterfield J., et al. Cystic emphysema in premature infants: a report of an outbreak with the isolation of type 19 ECHO virus in one case. N. Engl. J. Med. 1963, 268:18.
261. Cramblett H.G., et al. Nosocomial infection with echovirus type 11 in handicapped and premature infants. Pediatrics 1973, 51:603.
262. Davies D.P., et al. Echovirus-11 infection in a special-care baby unit. Lancet 1979, 1:96.
263. Eichenwald H.F., et al. Epidemic diarrhea in premature and older infants caused by ECHO virus type 18. JAMA 1958, 166:1563.
264. Eichenwald H.F., Kostevalov O., Fasso L.A. The "cloud baby": an example of bacterial-viral interaction. Am. J. Dis. Child. 1960, 100:161.
265. Faulkner R.S., van Rooyen C.E. Echovirus type 17 in the neonate. Can. Med. Assoc. J. 1973, 108:878.
266. German L.J., McCracken A.W., Wilkie K.M. Outbreak of febrile illness associated with ECHO virus type 5 in a maternity unit in Singapore. BMJ 1968, 1:742.
267. Hart E.W., et al. Infection of newborn babies with ECHO virus type 5. Lancet 1962, 2:402.
268. Hasegawa A. Virologic and serologic studies on an outbreak of echovirus type 11 infection in a hospital maternity unit. Jpn. J. Med. Sci. Biol. 1975, 28:179.
269. Hercík L., et al. Epidemien der Respirationstrakterkrankunger bei Neugeborenen durch ECHO 11-Virus. Zentrabl. Bakteriol. 1970, 213:18.
270. Jack I., et al. A survey of prenatal virus disease in Melbourne. Personal communication. July 1967, 21.
271. Kapsenberg J.G. ECHO virus type 33 as a cause of meningitis. Arch. Gesamte Virusforsch. 1968, 23:144.
272. Kinney J.S., et al. Risk factors associated with echovirus 11 infection in a hospital nursery. Pediatr. Infect. Dis. 1986, 5:192.
273. Lapinleimu K., Hakulinen A. A hospital outbreak caused by ECHO virus type 11 among newborn infants. Ann. Clin. Res. 1972, 4:183.
274. McDonald L.L. St. Geme JW, Arnold BH. Nosocomial infection with ECHO virus type 31 in a neonatal intensive care unit. Pediatrics 1971, 47:995.
275. Mertens T., Hager H., Eggers H.J. Epidemiology of an outbreak in a maternity unit of infections with an antigenic variant of echovirus 11. J. Med. Virol. 1982, 9:81.
276. Miller D.G., et al. An epidemic of aseptic meningitis, primarily among infants, caused by echovirus 11-prime. Pediatrics 1968, 41:77.
277. Modlin J.F. Fatal echovirus 11 disease in premature neonates. Pediatrics 1980, 66:775.
278. Modlin J.F. Echovirus infections of newborn infants. Pediatr. Infect. Dis. 1988, 7:311.
279. Nagington J., et al. Fatal echovirus 11 infections in outbreak in special-care baby unit. Lancet 1978, 2:725.
280. Nakao T., Miura R., Sato M. ECHO virus type 22 in a premature infant, Tohoku. J. Exp. Med. 1970, 102:61.
281. Purdham D.R., et al. Severe ECHO 19 virus infection in a neonatal unit. Arch. Dis. Child. 1976, 51:634.
282. Rabkin C.S., et al. Outbreak of echovirus 11 infection in hospitalized neonates. Pediatr. Infect. Dis. J. 1988, 7:186.
283. Sanders D.Y., Cramblett H.G. Viral infections in hospitalized neonates. Am. J. Dis. Child. 1968, 116:251.
284. Steinmann J., Albrecht K. Echovirus 11 epidemic among premature newborns in a neonatal intensive care unit. Zentralbl. Bakteriol. Mikrobiol. Hyg. 1985, 259:284.
285. Wilson C.W., Stevenson D.K., Arvin A.M. A concurrent epidemic of respiratory syncytial virus and echovirus 7 infections in an intensive care nursery. Pediatr. Infect. Dis. J. 1989, 8:24.
286. Wreghitt T.G., et al. Fatal echovirus 7 infection during an outbreak in a special care baby unit. J. Infect. 1989, 19:229.
287. Sato K., et al. A new-born baby outbreak of echovirus type 33 infection. J. Infect. 1998, 37:123.
288. Verlinde J.D., Versteeg J., Beeuwkes H. Mogelijkheid van een besmetting van de mens door varkens lijdende aan een Coxsackievirus pneumonie. Ned. Tijdschr. Geneeskd. 1958, 102:1445.
289. Moscovici C., et al. Virus 1956 R.C. Ann. Ist. Super. Sanita. 1957, 20:1137.
290. Lundgren D.L., Clapper W.E., Sanchez A. Isolation of human enteroviruses from beagle dogs. Proc. Soc. Exp. Biol. Med. 1968, 128:463.
291. Lundgren D.L., et al. A survey for human enteroviruses in dogs and man. Arch. Gesamte. Virusforsch. 1970, 32:229.
292. Koprowski H. Counterparts of human viral disease in animals. Ann. N. Y. Acad. Sci. 1958, 70:369.
293. Sommerville R.G., Type I. poliovirus isolated from a budgerigar. Lancet 1959, 1:495.
294. Makower H., Skurska Z. Badania nad wirusami Coxsackie, Doniesienie III. Izolacja wirusa Coxsackie z mózgu lisa. Arch. Immunol. Ter. Dosw. 1957, 5:219.
295. Bendinelli M., Ruschi A. Isolation of human enterovirus from mussels. Appl. Microbiol. 1969, 18:531.
296. Metcalf T.G., Stiles W.C. Enterovirus within an estuarine environment. Am. J. Epidemiol. 1968, 88:379.
297. Horstmann D.M., Manuelidis E.E. Russian Coxsackie A-7 virus ("AB IV" strain)-neuropathogenicity and comparison with poliovirus. J. Immunol. 1958, 81:32.
298. Bartell P., Klein M. Neutralizing antibody to viruses of poliomyelitis in sera of domestic animals. Proc. Soc. Exp. Biol. Med. 1955, 90:597.
299. Morris J.A., O'Connor J.R. Neutralization of the viruses of the Coxsackie group by sera of wild rabbits. Cornell Vet. 1952, 42:56.
300. Chang P.W., et al. Multiplication of human enteroviruses in northern quahogs. Proc. Soc. Exp. Biol. Med. 1971, 136:1380.
301. Metcalf T.G., Stiles W.C. Accumulation of enteric viruses by the oyster, Crassostrea. virginica. J. Infect. Dis. 1965, 115:68.
302. Atwood R.P., Cherry J.D., Klein J.O. Clams and viruses. Hepat. Surveill. Rep. 1964, 20:26.
303. Duff M.F. The uptake of enteroviruses by the New Zealand marine blue mussel Mytilus edulis aoteanus. Am. J. Epidemiol. 1967, 85:486.
304. Liu O.C., Seraichekas H.R., Murphy B.L. Viral depuration of the Northern quahaug. Appl. Microbiol. 1967, 15:307.
305. Lynt R.K. Survival and recovery of enterovirus from foods. Appl. Microbiol. 1966, 14:218.
306. Kalter S.S. A serological survey of antibodies to selected enteroviruses. Bull. World Health Organ. 1962, 26:759.
307. Centers for Disease Control Enterovirus Surveillance, Summary 1970-1979 1981, November.
308. Bodian D., Horstmann D.M. Poliomyelitis 1965, Lippincott, Philadelphia.
309. Assaad F., Ljungars-Esteves K. World overview of poliomyelitis: regional patterns and trends. Rev. Infect. Dis. 1984, 6:S302.
310. Phillips C.A., et al. Enteroviruses in Vermont, 1969-1978: an important cause of illness throughout the year. J. Infect. Dis. 1980, 141:162.
311. Drebit M.A., et al. Molecular epidemiology of enterovirus outbreaks in Canada during 1991-1992: identification of echovirus 30 and coxsackievirus B1 strains by amplicon sequencing. J. Med. Virol. 1994, 44:340.
312. Ishiko H., et al. Phylogenetic analysis of a coxsackievirus A24 variant: the most recent worldwide pandemic was caused by progenies of a virus prevalent around 1981. Virology 1992, 187:748.
313. Lin K.H., et al. Molecular epidemiology of a variant of coxsackievirus A24 in Taiwan: two epidemics caused by phylogenetically distinct viruses from 1985 to 1989. J. Clin. Microbiol. 1993, 31:1160.
314. Mulders M.N., et al. Molecular epidemiology of wild poliovirus type 1 in Europe, the Middle East, and the Indian subcontinent. J. Infect. Dis. 1995, 171:1399.
315. Increased detections and severe neonatal disease associated with coxsackievirus B1 infection-United States, 2007. MMWR Morb. Mortal. Wkly Rep. 2008, 57:553-556.
316. Enterovirus surveillance-United States, 1985. MMWR Morb. Mortal. Wkly Rep. 1985, 34:494-495.
317. From the Centers for Disease Control and Prevention Nonpolio enterovirus surveillance-United States, 1993-1996. JAMA 1997, 278:975.
318. Enterovirus surveillance-United States, 1997-1999. MMWR Morb. Mortal. Wkly Rep. 2000, 49:913-916.
319. Enterovirus surveillance-United States, 2000-2001. MMWR Morb. Mortal. Wkly Rep. 2002, 51:1047-1049.
320. Enterovirus surveillance-United States, 2002-2004. MMWR Morb. Mortal. Wkly Rep. 2006, 55:153-156.
321. Alexander J.P., Anderson L.J. Respiratory and Enterovirus Branch, Centers for Disease Control and Prevention 1990, Personal communication.
322. Gary H. Respiratory and Enteric Viruses Branch, Centers for Disease Control and Prevention 1996, Personal communication.
323. Strikas R.A., Anderson L.J., Parker R.A. Temporal and geographic patterns of isolates of nonpolio enterovirus in the United States, 1970-1983. J. Infect. Dis. 1986, 153:346.
324. Druyts-Voets E. Epidemiological features of entero non-poliovirus isolations in Belgium 1980-94. Epidemiol. Infect. 1997, 119:71.
325. Trallero G., et al. Enteroviruses in Spain: virological and epidemiological studies over 10 years (1988-97). Epidemiol. Infect. 2000, 124:497.
326. Brown B.A., et al. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J. Virol. 1999, 73:9969.
327. Chan L.G., et al. Deaths of children during an outbreak of hand, foot, and mouth disease in Sarawak, Malaysia: clinical and pathological characteristics of the disease. Clin. Infect. Dis. 2000, 31:678.
328. Ho M., et al. An epidemic of enterovirus 71 infection in Taiwan. N. Engl. J. Med. 1999, 341:929.
329. Komatsu H., et al. Outbreak of severe neurologic involvement associated with enterovirus 71 infection. Pediatr. Neurol. 1999, 20:17.
330. Center for Disease Control Neurotropic Diseases Surveillance, No. 3. Annual Summary 1970, U.S. Department of Health, Education, and Welfare, Washington, DC.
331. Communicable Disease Center Poliomyelitis Surveillance, No. 274 1963, U.S. Department of Health, Education, and Welfare, Washington, DC.
332. Horstmann D.B., et al. Enterovirus surveillance following a community-wide oral poliovirus vaccination program: a seven-year study. Am. J. Epidemiol. 1973, 97:173.
333. Batcup G., et al. Placental and fetal pathology in coxsackie virus A9 infection: a case report. Histopathology 1985, 9:1227.
334. Ramsingh A.I., Collins D.N. A point mutation in the VP4 coding sequence of coxsackievirus B4 influences virulence. J. Virol. 1995, 69:7278.
335. Rinehart J.E., Gomez R.M., Roos R.P. Molecular determinants for virulence in coxsackievirus B1 infection. J. Virol. 1997, 71:3986.
336. Heineberg H., Gold E., Robbins F.C. Differences in interferon content in tissues of mice of various ages infected with coxsackie B1 virus. Proc. Soc. Exp. Biol. Med. 1964, 115:947.
337. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 2007, 7:379-390.
338. Behbehani A.M., Sulkin S.E., Wallis C. Factors influencing susceptibility of mice to coxsackie virus infection. J. Infect. Dis. 1962, 110:147.
339. Boring W.D., Angevine D.M., Walker D.L. Factors influencing host-virus interactions. I. A comparison of viral multiplication and histopathology in infant, adult, and cortisone-treated adult mice infected with the Conn-5 strain of coxsackie virus. J. Exp. Med. 1955, 102:753.
340. Kunin C.W. Cellular susceptibility to enteroviruses. Bacteriol. Rev. 1964, 28:382.
341. Kunin C.M. Virus-tissue union and the pathogenesis of enterovirus infections. J. Immunol. 1962, 88:556.
342. Ito M., et al. Expression of coxsackievirus and adenovirus receptor in hearts of rats with experimental autoimmune myocarditis. Circ. Res. 2000, 86:275-280.
343. Teisner B., Haahr S. Poikilothermia and susceptibility of suckling mice to coxsackie B1 virus. Nature 1974, 247:568.
344. McManus B.M., et al. Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis. Clin. Immunol. Immunopathol. 1993, 68:159.
345. Arola A., et al. Experimental myocarditis induced by two different coxsackievirus B3 variants: aspects of pathogenesis and comparison of diagnostic methods. J. Med. Virol. 1995, 47:251.
346. Chehadeh W., et al. Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackievirus B infection. J. Infect. Dis. 2000, 181:1929.
347. Gauntt C.J., et al. Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis. J. Immunol. 1995, 154:2983.
348. Gauntt C.J., et al. Epitopes shared between coxsackievirus B3 (CVB3) and normal heart tissue contribute to CVB3-induced murine myocarditis. Clin. Immunol. Immunopathol. 1993, 68:129.
349. Herskowitz A., et al. Coxsackievirus B3 murine myocarditis: wide pathologic spectrum in genetically defined inbred strains. Hum. Pathol. 1985, 16:671.
350. Hosier D.M., Newton W.A. Serious coxsackie infection in infants and children: myocarditis, meningoencephalitis, and hepatitis. Am. J. Dis. Child. 1958, 96:251.
351. Juhela S., et al. T-cell responses to enterovirus antigens in children with type 1 diabetes. Diabetes 2000, 49:1308.
352. Pague R.E. Role of anti-idiotypic antibodies in induction, regulation, and expression of coxsackievirus-induced myocarditis. Prog. Med. Virol. 1992, 39:204.
353. Rabausch-Starz I., et al. Persistence of virus and viral genome in myocardium after coxsackievirus B3-induced murine myocarditis. Clin. Exp. Immunol. 1994, 96:69.
354. Seko Y., et al. Restricted usage of T-cell receptor Va genes in infiltrating cells in murine hearts with acute myocarditis caused by coxsackie virus B3. J. Pathol. 1996, 178:330.
355. Philipson L. Association between a recently isolated virus and an epidemic of upper respiratory disease in a day nursery. Arch. Gesamte Virusforsch. 1958, 8:204-215.
356. Cherry J.D., et al. Echo 11 virus infections associated with exanthems. Pediatrics 1963, 32:509-516.
357. Berry P.J., Nagington J. Fatal infection with echovirus 11. Arch. Dis. Child. 1982, 57:22.
358. Bose C.L., et al. Dissimilar manifestations of intrauterine infection with echovirus 11 in premature twins. Arch. Pathol. Lab. Med. 1983, 107:361.
359. Gh M.M., et al. Postmortem manifestations of echovirus 11 sepsis in five newborn infants. Hum. Pathol. 1983, 14:818.
360. Gitlin N., et al. Fulminant neonatal hepatic necrosis associated with echovirus type 11 infection. West. J. Med. 1983, 138:260.
361. Halfon N., Spector S.A. Fatal echovirus type 11 infections. Am. J. Dis. Child. 1981, 135:1017.
362. Jones M.J., et al. Intrauterine echovirus type 11 infection. Mayo Clin. Proc. 1980, 55:509.
363. Krous H.F., Dietzman D., Ray C.G. Fatal infections with echovirus types 6 and 11 in early infancy. Am. J. Dis. Child. 1973, 126:842.
364. Wang J., et al. Echovirus hepatic failure in infancy: report of four cases with speculation on the pathogenesis. Pediatr. Dev. Pathol. 2001, 4:454.
365. Kennett M.L., et al. Enterovirus type 71 infection in Melbourne. Bull. World Health Organ. 1974, 51:609-615.
366. Schmidt N.J., Lennette E.H., Ho H.H. An apparently new enterovirus isolated from patients with disease of the central nervous system. J. Infect. Dis. 1974, 129:304.
367. Cardosa M.J., et al. Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes. Emerg. Infect. Dis. 2003, 9:461-468.
368. Chan K.P., et al. Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg. Infect. Dis. 2003, 9:78-85.
369. Chan L.G., et al. Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease, For the Outbreak Study Group. Clin. Infect. Dis. 2000, 31:678-683.
370. Chang L.Y., et al. Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. JAMA 2004, 291:222-227.
371. Chong C.Y., et al. Hand, foot and mouth disease in Singapore: a comparison of fatal and non-fatal cases. Acta Paediatr. 2003, 92:1163-1169.
372. Hosoya M., et al. Genetic diversity of enterovirus 71 associated with hand, foot and mouth disease epidemics in Japan from 1983 to 2003. Pediatr. Infect. Dis. J. 2006, 25:691-694.
373. Li C.C., et al. Clinical manifestations and laboratory assessment in an enterovirus 71 outbreak in southern Taiwan. Scand. J. Infect. Dis. 2002, 34:104-109.
374. Lu C.Y., et al. Incidence and case-fatality rates resulting from the 1998 enterovirus 71 outbreak in Taiwan. J. Med. Virol. 2002, 67:217-223.
375. Kew O., et al. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 2002, 296:356-359.
376. Santti J., et al. Evidence of recombination among enteroviruses. J. Virol. 1999, 73:8741-8749.
377. Simmonds P., Welch J. Frequency and dynamics of recombination within different species of human enteroviruses. J. Virol. 2006, 80:483-493.
378. Baker D.A., Phillips C.A. Maternal and neonatal infection with coxsackievirus. Obstet. Gynecol. 1980, 55:12S.
379. Balduzzi P.C., Greendyke R.M. Sudden unexpected death in infancy and viral infection. Pediatrics 1966, 38:201.
380. Gold E., et al. Viral infection: a possible cause of sudden, unexpected death in infants. N. Engl. J. Med. 1961, 264:53.
381. Eisenhut M., et al. Fatal coxsackie A9 virus infection during an outbreak in a neonatal unit. J. Infect. 2000, 40:297.
382. Konen O., et al. Progressive liver calcifications in neonatal coxsackievirus infection. Pediatr. Radiol. 2000, 30:343.
383. Piraino F.F., Sedmak G., Raab K. Echovirus 11 infections of newborns with mortality during the 1979 enterovirus season in Milwaukee, Wisc. Public Health Rep. 1982, 97:346.
384. Chambon M., et al. Fatal hepatitis necrosis in a neonate with echovirus 20 infection: use of the polymerase chain reaction to detect enterovirus in the liver tissue. Clin. Infect. Dis. 1997, 24:523.
385. Georgieff M.K., et al. Fulminant hepatic necrosis in an infant with perinatally acquired echovirus 21 infection. Pediatr. Infect. Dis. 1987, 6:71.
386. Philip A.G.S., Larson E.J. Overwhelming neonatal infection with ECHO 19 virus. J. Pediatr. 1973, 82:391.
387. Rawls W.E., Shorter R.G., Herrmann E.C. Fatal neonatal illness associated with ECHO 9 (coxsackie A-23) virus. Pediatrics 1964, 33:278.
388. Ventura K., et al. Fatal neonatal echovirus 6 infection: autopsy case report and review of the literature. Mod. Pathol. 2001, 14:85.
389. Wreghitt T.G., et al. Fatal neonatal echo 7 virus infection. Lancet 1984, 2:465.
390. Cheeseman S.H., et al. Fatal neonatal pneumonia caused by echovirus type 9. Am. J. Dis. Child. 1977, 131:1169.
391. Boyd M.T., Jordan S.W., Davis L.E. Fatal pneumonitis from congenital echovirus type 6 infection. Pediatr. Infect. Dis. J. 1987, 6:1138.
392. Willems A., et al. Fatal illness associated with pulmonary hypertension in a neonate caused by intrauterine echovirus 11 infection. Am. J. Perinatol. 2006, 23:59-61.
393. Anderson G.W., et al. Poliomyelitis in pregnancy. Am. J. Hyg. 1952, 55:127.
394. Aycock W.L., Ingalls T.H. Maternal disease as a principle in the epidemiology of congenital anomalies. Am. J. Med. Sci. 1946, 212:366.
395. Bowers V.M., Danforth D.N. The significance of poliomyelitis during pregnancy-an analysis of the literature and presentation of twenty-four new cases. Am. J. Obstet. Gynecol. 1953, 65:34.
396. Schaefer J., Shaw E.B. Poliomyelitis in pregnancy. Calif. Med. 1949, 70:16.
397. Kaye B.M., Rosner D.C., Stein I. Viral diseases in pregnancy and their effect upon the embryo and fetus. Am. J. Obstet. Gynecol. 1953, 65:109.
398. Harjulehto-Mervaala T., et al. Oral polio vaccination during pregnancy: lack of impact on fetal development and perinatal outcome. Clin. Infect. Dis. 1994, 18:414.
399. Frisk G., Diderholm H. Increased frequency of coxsackie B virus IgM in women with spontaneous abortion. J. Infect. 1992, 24:141.
400. Axelsson C., et al. Coxsackie B virus infections in women with miscarriage. J. Med. Virol. 1993, 39:282.
401. Berendes H.W., et al. The NIH collaborative study. A progress report 1969.
402. News and Notes Polio vaccine and congenital defects. BMJ 1967, 1:510.
403. Connelly J.P., et al. Viral and drug hazards in pregnancy. Clin. Pediatr. 1964, 3:587.
404. Harjulehto T., et al. Congenital malformations and oral poliovirus vaccination during pregnancy. Lancet 1989, 1:771.
405. Brown G.C. Maternal virus infection and congenital anomalies. Arch. Environ. Health 1970, 21:362.
406. Brown G.C. Recent advances in the viral aetiology of congenital anomalies. Adv. Teratol. 1966, 1:55.
407. Brown G.C. Coxsackie virus infections and heart disease. Am. Heart J. 1968, 75:145.
408. Evans T.N., Brown G.C. Congenital anomalies and virus infections. Am. J. Obstet. Gynecol. 1963, 87:749.
409. Brown G.C., Evans T.N. Serologic evidence of coxsackievirus etiology of congenital heart disease. JAMA 1967, 199:183.
410. Brown G.C., Karunas R.S. Relationship of congenital anomalies and maternal infection with selected enteroviruses. Am. J. Epidemiol. 1972, 95:207.
411. Elizan T.S., et al. Viral infection in pregnancy and congenital CNS malformations in man. Arch. Neurol. 1969, 20:115.
412. Gauntt C.J., et al. Coxsackievirus group B antibodies in the ventricular fluid of infants with severe anatomic defects in the central nervous system. Pediatrics 1985, 76:64.
413. Aycock W.L. Acute poliomyelitis in pregnancy: its occurrence according to month of pregnancy and sex of fetus. N. Engl. J. Med. 1946, 235:160.
414. Ouellet A., et al. Antenatal diagnosis of intrauterine infection with coxsackievirus B3 associated with live birth. Infect. Dis. Obstet. Gynecol. 2004, 12:23-26.
415. Freedman P.S. Echovirus 11 infection and intrauterine death. Lancet 1979, 1:96.
416. Nielsen J.L., Berryman G.K., Hankins G.D. Intrauterine fetal death and the isolation of echovirus 27 from amniotic fluid. J. Infect. Dis. 1988, 158:501.
417. Barton L.L. Febrile neonatal illness associated with echo virus type 5 in the cerebrospinal fluid. Clin. Pediatr. 1977, 16:383.
418. Estes M.L., Rorke L.B. Liquefactive necrosis in coxsackie B encephalitis. Arch. Pathol. Lab. Med. 1986, 110:1090.
419. Farmer K., Patten P.T. An outbreak of coxsackie B5 infection in a special care unit for newborn infants. N. Z. Med. J. 1968, 68:86.
420. Morens D.M. Enteroviral disease in early infancy. J. Pediatr. 1978, 92:374.
421. News and Notes Coxsackie B virus infections in 1971. BMJ 1972, 1:453.
422. Bina Rai S., et al. An outbreak of echovirus 11 amongst neonates in a confinement home in Penang, Malaysia. Med. J. Malaysia 2007, 62:223-226.
423. Eilard T., et al. An outbreak of coxsackie virus type B2 among neonates in an obstetrical ward. Acta Paediatr. Scand. 1974, 63:103.
424. Benschop K.S., et al. Fourth human parechovirus serotype. Emerg. Infect. Dis. 2006, 12:1572-1575.
425. Fox J.P. Epidemiological aspects of coxsackie and ECHO virus infections in tropical areas. Am. J. Public Health 1964, 54:1134.
426. Barre V., et al. Enterovirus-associated haemophagocytic syndrome in a neonate. Acta Paediatr. 1998, 87:467.
427. Lake A.M., et al. Enterovirus infections in neonates. J. Pediatr. 1976, 89:787.
428. Bacon C.J., Sims D.G. Echovirus 19 infection in infants under six months. Arch. Dis. Child. 1976, 51:631.
429. Benschop K.S., et al. Human parechovirus infections in Dutch children and the association between serotype and disease severity. Clin. Infect. Dis. 2006, 42:204-210.
430. Boivin G., Abed Y., Boucher F.D. Human parechovirus 3 and neonatal infections. Emerg. Infect. Dis. 2005, 11:103-105.
431. Chen C.A., et al. Severe echovirus 30 infection in twin neonates. J. Formos. Med. Assoc. 2003, 102:59-61.
432. Chen J.H., et al. A neonatal echovirus 11 outbreak in an obstetric clinic. J. Microbiol. Immunol. Infect. 2005, 38:332-337.
433. Cho C.T., Janelle J.G., Behbehani A. Severe neonatal illness associated with ECHO 9 virus infection. Clin. Pediatr. 1973, 12:304.
434. Codd A.A., et al. Epidemic of echovirus 19 in the northeast of England. J. Hyg. (Lond.) 1976, 76:307.
435. Grossman M., Azimi P. Fever, hepatitis and coagulopathy in a newborn infant. Pediatr. Infect. Dis. J. 1992, 11:1069.
436. Hall C.B., et al. The return of Boston exanthem. Am. J. Dis. Child. 1977, 131:323.
437. Linnemann C.C., et al. Febrile illness in early infancy associated with ECHO virus infection. J. Pediatr. 1974, 84:49.
438. Marier R., et al. Coxsackievirus B5 infection and aseptic meningitis in neonates and children. Am. J. Dis. Child. 1975, 129:321.
439. Pino-Ramirez R.M., et al. Neonatal echovirus 30 infection associated with severe hepatitis in twin neonates. Pediatr. Infect. Dis. J. 2008, 27:88.
440. Tang J.W., Bendig J.W., Ossuetta I. Vertical transmission of human echovirus 11 at the time of Bornholm disease in late pregnancy. Pediatr. Infect. Dis. J. 2005, 24:88-89.
441. Wong S.N., et al. Fatal coxsackie B1 virus infection in neonates. Pediatr. Infect. Dis. J. 1989, 8:638.
442. Yen H., et al. Hepatic failure in a newborn with maternal peripartum exposure to echovirus 6 and enterovirus 71. Eur. J. Pediatr. 2003, 162:648.
443. Verboon-Maciolek M.A., et al. Severe neonatal echovirus 20 infection characterized by hepatic failure. Pediatr. Infect. Dis. J. 1997, 16:524.
444. Hober D., et al. Coxsackievirus B3-induced chronic myocarditis in mouse: use of whole blood culture to study the activation of TNF alpha-producing cells. Microbiol. Immunol. 1996, 40:837.
445. Chawareewong S., et al. Neonatal herpangina caused by coxsackie A-5 virus. J. Pediatr. 1978, 93:492.
446. Murray D., Altschul M., Dyke J. Aseptic meningitis in a neonate with an oral vesicular lesion. Diagn. Microbiol. Infect. Dis. 1985, 3:77.
447. Nakayama T., et al. Outbreak of herpangina associated with coxsackievirus B3 infection. Pediatr. Infect. Dis. J. 1989, 8:495.
448. Suzuki N., et al. Age-related symptomatology of ECHO 11 virus infection in children. Pediatrics 1980, 65:284.
449. Eckert H.L., et al. Group B Coxsackie virus infection in infants with acute lower respiratory disease. Pediatrics 1967, 39:526.
450. Chonmaitree T., et al. Enterovirus 71 infection: report of an outbreak with two cases of paralysis and a review of the literature. Pediatrics 1981, 67:489.
451. Mirani M., Ogra P.L., Barron A. Epidemic of echovirus type 9 infection: certain clinical and epidemiologic features. N. Y. J. Med. 1973, 73:403.
452. Ramos-Alvarez M. Cytopathogenic enteric viruses associated with undifferentiated diarrheal syndromes in early childhood. Ann. N. Y. Acad. Sci. 1957, 67:326.
453. Bauer S., et al. Severe coxsackie virus B infection in preterm newborns treated with pleconaril. Eur. J. Pediatr. 2002, 161:491.
454. Iwasaki T., et al. An immunofluorescent study of generalized coxsackie virus B3 infection in a newborn infant. Acta Pathol. Jpn. 1985, 35:741.
455. Abzug M.J. Prognosis for neonates with enterovirus hepatitis and coagulopathy. Pediatr. Infect. Dis. J. 2001, 20:758.
456. Boccia D., et al. Nosocomial necrotising enterocolitis outbreaks: epidemiology and control measures. Eur. J. Pediatr. 2001, 160:385.
457. Barson W.J., et al. Survival following myocarditis and myocardial calcification associated with infection by coxsackie virus B4. Pediatrics 1981, 68:79.
458. Chan S.H., Lun K.S. Ventricular aneurysm complicating neonatal coxsackie B4 myocarditis. Pediatr. Cardiol. 2001, 22:247.
459. Chonmaitree T., Menegus M.A., Powell K.R. The clinical relevance of "CSF viral culture." A two-year experience with aseptic meningitis in Rochester, N.Y. JAMA 1982, 247:1843.
460. Drew J.H. ECHO 11 virus outbreak in a nursery associated with myocarditis. Aust. Paediatr. J. 1973, 9:90.
461. Rantakallio P., et al. Follow-up study of 17 cases of neonatal coxsackie B5 meningitis and one with suspected myocarditis. Scand. J. Infect. Dis. 1970, 2:25.
462. Simmonds J., et al. Successful heart transplantation following neonatal necrotic enterovirus myocarditis. Pediatr. Cardiol. 2008, 29:834-837.
463. Smets K., et al. Detection of enteroviral RNA on Guthrie card dried blood of a neonate with fatal Coxsackie B3 myocarditis on day 17. J. Clin. Virol. 2008, 42:207-210.
464. Talsma M., Vegting M., Hess J. Generalised coxsackie A9 infection in a neonate presenting with pericarditis. Br. Heart J. 1984, 52:683.
465. Cramblett H.G., et al. ECHO 19 virus infections. Arch. Intern. Med. 1962, 110:574.
466. Abzug M.J., Levin M.J., Rotbart H.A. Profile of enterovirus disease in the first two weeks of life. Pediatr. Infect. Dis. J. 1993, 12:820.
467. Daboval T., Ferretti E., Duperval R. High C-reactive protein levels during a benign neonatal outbreak of echovirus type 7. Am. J. Perinatol. 2006, 23:299-304.
468. Haddad J., et al. Enterovirus infections in neonates: a retrospective study of 21 cases. Eur. J. Med. 1993, 2:209.
469. Kusuhara K., et al. An echovirus type 18 outbreak in a neonatal intensive care unit. Eur. J. Pediatr. 2008, 167:587-589.
470. Theodoridou M., et al. Vesiculopapular rash as a single presentation in intrauterine coxsackie virus infection. Eur. J. Pediatr. 2002, 161:412.
471. Chen C.Y., et al. Acute flaccid paralysis in infants and young children with enterovirus 71 infection: MR imaging findings and clinical correlates. AJNR Am. J. Neuroradiol. 2001, 22:200.
472. Barson W.J., Reiner C.B. Coxsackievirus B2 infection in a neonate with incontinentia pigmenti. Pediatrics 1986, 77:897.
473. Bergman I., et al. Outcome in children with enteroviral meningitis during the first year of life. J. Pediatr. 1987, 110:705.
474. Blokziji M.L., Koskiniemi M. Echovirus 6 encephalitis in a preterm baby. Lancet 1989, 2:164.
475. Bowen G.S., et al. Epidemic of meningitis and febrile illness in neonates caused by echo type 11 virus in Philadelphia. Pediatr. Infect. Dis. 1983, 2:359.
476. Callen J., Paes B.A. A case report of a premature infant with coxsackie B1 meningitis. Adv. Neonatal. Care 2007, 7:238-247.
477. Cherry J.D., et al. Coxsackie B5 infections with exanthems. Pediatrics 1963, 31:445.
478. Chesney P.J., Quennec P., Clark C. Hypoglycorrhachia and coxsackie B3 meningoencephalitis. Am. J. Clin. Pathol. 1978, 70:947.
479. Ehrnst A., Eriksson M. Echovirus type 23 observed as a nosocomial infection in infants. Scand. J. Dis. 1996, 28:205.
480. Farmer K., MacArthur B.A., Clay M.M. A follow-up study of 15 cases of neonatal meningoencephalitis due to coxsackie virus B5. J. Pediatr. 1975, 87:568.
481. Haynes R.E., et al. ECHO virus type 3 infections in children: clinical and laboratory studies. J. Pediatr. 1972, 80:589.
482. Haynes R.E., Cramblett H.G., Kronfol H.J. Echovirus 9 meningoencephalitis in infants and children. JAMA 1969, 208:1657.
483. Helin I., et al. Outbreak of coxsackievirus A-14 meningitis among newborns in a maternity hospital ward. Acta Paediatr. Scand. 1987, 76:234.
484. Johnson R.T., Shuey H.E., Buescher E.L. Epidemic central nervous system disease of mixed enterovirus etiology, I. Clinical and epidemiologic description. Am. J. Hyg. 1960, 71:321.
485. Matsumoto K., et al. Characterization of an echovirus type 30 variant isolated from patients with aseptic meningitis. Microbiol. Immunol. 1986, 30:333.
486. Schurmann W., et al. Two cases of coxsackie B2 infection in neonates: clinical, virological, and epidemiological aspects. Eur. J. Pediatr. 1983, 140:59.
487. Sells C.J., Carpenter R.L., Ray C.G. Sequelae of central-nervous-system enterovirus infections. N. Engl. J. Med. 1975, 293:1.
488. Sumaya C.V., Corman L.I. Enteroviral meningitis in early infancy: significance in community outbreaks. Pediatr. Infect. Dis. 1982, 1:151.
489. King R.L., et al. Routine cerebrospinal fluid enterovirus polymerase chain reaction testing reduces hospitalization and antibiotic use for infants 90 days of age or younger. Pediatrics 2007, 120:489-496.
490. Tavakoli N.P., et al. Detection and typing of enteroviruses from CSF specimens from patients diagnosed with meningitis/encephalitis. J. Clin. Virol. 2008, 43:207-211.
491. Verboon-Maciolek M.A., et al. Human parechovirus causes encephalitis with white matter injury in neonates. Ann. Neurol. 2008, 64:266-273.
492. Kew O., et al. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 2002, 296:356.
493. Arnon R., et al. Fatal outcome of neonatal echovirus 19 infection. Pediatr. Infect. Dis. J. 1991, 10:788.
494. Grangeot-Keros L., et al. Enterovirus in sudden unexpected deaths in infants. Pediatr. Infect. Dis. J. 1996, 15:123.
495. Paul J.R. Epidemiology of poliomyelitis. Monogr. Ser. World Health Organ 1955, 26:9.
496. Weibel R.E., Benor D.E. Reporting vaccine-associated paralytic poliomyelitis: concordance between the CDC and the National Vaccine Injury Compensation Program. Am. J. Public Health 1996, 86:734.
497. Wolfgram L.J., Rose N.R. Coxsackievirus infection as a trigger of cardiac autoimmunity. Immunol. Res. 1989, 8:61.
498. Wilfert C.M., et al. Longitudinal assessment of children with enteroviral meningitis during the first three months of life. Pediatrics 1981, 67:811.
499. Yen H.R., et al. Hepatic failure in a newborn with maternal peripartum exposure to echovirus 6 and enterovirus 71. Eur. J. Pediatr. 2003, 162:648-649.
500. Aradottir E., Alonso E., Shulman S. Severe neonatal enteroviral hepatitis treated with pleconaril. Pediatr. Infect. Dis. J. 2001, 20:e457.
501. Sabin A.B., Krumbiegel E.R., Wigand R. ECHO type 9 virus disease. Am. J. Dis. Child. 1958, 96:197.
502. Toce S.S., Keenan W.J. Congenital echovirus 11 pneumonia in association with pulmonary hypertension. Pediatr. Infect. Dis. J. 1988, 7:360.
503. Tarcan A., Özbek N., Gürakan B. Bone marrow failure with concurrent enteroviral infection in a newborn. Pediatr. Infect. Dis. J. 2001, 20:e719.
504. Chen K.T., et al. Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan, 1998-2005. Pediatrics 2007, 120:e244-e252.
505. Wilfert C.M., et al. An epidemic of echovirus 18 meningitis. J. Infect. Dis. 1975, 131:75.
506. Mullins J.A., et al. Emergence of echovirus type 13 as a prominent enterovirus. Clin. Infect. Dis. 2004, 38:70.
507. Kirschke D.L., et al. Outbreak of aseptic meningitis associated with echovirus 13. Pediatr. Infect. Dis. J. 2002, 21:1034.
508. Somekh E., et al. An outbreak of echovirus 13 meningitis in central Israel. Epidemiol. Infect. 2003, 130:257.
509. Trallero G., et al. First epidemic of aseptic meningitis due to echovirus type 13 among Spanish children. Epidemiol. Infect. 2003, 130:251.
510. Drouhet V. Enterovirus infection and associated clinical symptoms in children. Ann. Inst. Pasteur. 1960, 98:562.
511. Hinuma Y., Murai Y., Nakao T. Two outbreaks of echovirus 14 infection: a possible interference with oral poliovirus vaccine and a probable association with aseptic meningitis. J. Hyg. (Lond). 1965, 63:277.
512. Medearis D.N., Kramer R.A. Exanthem associated with ECHO virus type 18 viremia. J. Pediatr. 1959, 55:367.
513. Chonmaitree T., et al. Comparison of cell cultures for rapid isolation of enteroviruses. J. Clin. Microbiol. 1988, 26:2576.
514. Johnson F.B. Transport of viral specimens. Clin. Microbiol. Rev. 1990, 3:120.
515. Howell C.L., Miller M.J. Effect of sucrose phosphate and sorbitol on infectivity of enveloped viruses during storage. J. Clin. Microbiol. 1983, 18:658.
516. August M.J., Warford A. Evaluation of a commercial monoclonal antibody for detection of adenovirus antigen. J. Clin. Microbiol. 1987, 25:2233.
517. Trabelsi A., et al. Evaluation of an enterovirus group-specific anti-VPI monoclonal antibody, 5-D8/1, in comparison with neutralization and PCR for rapid identification of enteroviruses in cell culture. J. Clin. Microbiol. 1995, 33:2454.
518. Carstens J.M., et al. Detection of enteroviruses in cell cultures by using in situ transcription. J. Clin. Microbiol. 1992, 30:25.
519. Abraham R., et al. Rapid detection of poliovirus by reverse transcription and polymerase chain amplification: application for the differentiation between poliovirus and nonpoliovirus enteroviruses. J. Clin. Microbiol. 1993, 31:295.
520. Rittichier K.R., et al. Diagnosis and outcomes of enterovirus infections in young infants. Pediatr. Infect. Dis. J. 2005, 24:546-550.
521. Martin A.B., et al. Acute myocarditis: rapid diagnosis by PCR in children. Circulation 1994, 90:330.
522. Muir P., et al. Multicenter quality assessment of PCR methods for detection of enteroviruses. J. Clin. Microbiol. 1999, 37:1409.
523. De L., et al. Identification of vaccine-related polioviruses by hybridization with specific RNA probes. J. Clin. Microbiol. 1995, 33:562.
524. Rotbart H.A. Nucleic acid detection systems for enteroviruses. Clin. Microbiol. Rev. 1991, 4:156.
525. Chezzi C. Rapid diagnosis of poliovirus infection by PCR amplification. J. Clin. Microbiol. 1996, 34:1722.
526. Egger D., et al. Reverse transcription multiplex PCR for differentiation between polio and enteroviruses from clinical and environmental samples. J. Clin. Microbiol. 1995, 33:1442.
527. Gorgievski-Hrisoho M., et al. Detection by PCR of enteroviruses in cerebrospinal fluid during a summer outbreak of aseptic meningitis in Switzerland. J. Clin. Microbiol. 1998, 36:2408.
528. Muir P., et al. Rapid diagnosis of enterovirus infection by magnetic bead extraction and polymerase chain reaction detection of enterovirus RNA in clinical specimens. J. Clin. Microbiol. 1993, 31:31.
529. Petitjean J., et al. Detection of enteroviruses in cerebrospinal fluids: enzymatic amplification and hybridization with a biotinylated riboprobe. Mol. Cell. Probes 1994, 8(15):B22.
530. Redline R.W., Genest D.R., Tycko B. Detection of enteroviral infection in paraffin-embedded tissue by the RNA polymerase chain reaction technique. Am. J. Clin. Pathol. 1991, 96:568.
531. Ramers C., et al. Impact of a diagnostic cerebrospinal fluid enterovirus polymerase chain reaction test on patient management. JAMA 2000, 283:2680.
532. Yang C.F., et al. Detection and identification of vaccine-related polioviruses by the polymerase chain reaction. Viral Res. 1991, 20(159):B79.
533. The Prevention of Mental Retardation Through Control of Infectious Diseases 1966, U.S. Government Printing Office, Washington, DC.
534. Dagan R., et al. Neutralizing antibodies to non-polio enteroviruses in human immune serum globulin. Pediatr. Infect. Dis. 1983, 2:454.
535. McKinney R.E., Katz S.L., Wilfert C.M. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev. Infect. Dis. 1987, 9:334.
536. Hammond G.W., et al. Maternal and neonatal neutralizing antibody titers to selected enteroviruses. Pediatr. Infect. Dis. 1985, 4:32.
537. Johnston J.M., Overall J.C. Intravenous immunoglobulin in disseminated neonatal echovirus 11 infection. Pediatr. Infect. Dis. J. 1989, 8:254.
538. Abzug M.J., et al. Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin. Clin. Infect. Dis. 1995, 20:1201.
539. Jantausch B.A., et al. Maternal plasma transfusion in the treatment of disseminated neonatal echovirus 11 infection. Pediatr. Infect. Dis. J. 1995, 14:154.
540. Chuang E., et al. Successful treatment of fulminant echovirus 11 infection in a neonate by orthotopic liver transplantation. J. Pediatr. Gastroenterol. Nutr. 1993, 17:211.
541. Bryant P.A., et al. Neonatal coxsackie B virus infection-a treatable disease?. Eur. J. Pediatr. 2004, 163:223-228.
542. Rotbart H.A., Abzug M.J., Levin M.J. Development and application of RNA probes for the study of picornaviruses. Mol. Cell. Probes 1988, 2:65.
543. Kilbourne E.D., Wilson C.B., Perrier D. The induction of gross myocardial lesions by a Coxsackie (pleurodynia) virus and cortisone. J. Clin. Invest. 1956, 35:367.
544. Mason J.W., et al. A clinical trial of immunosuppressive therapy for myocarditis. N. Engl. J. Med. 1995, 333:269.
545. Bell E.J., et al. Mu-antibody capture ELISA for the rapid diagnosis of enterovirus infections in patients with aseptic meningitis. J. Med. Virol. 1986, 19:213.
546. Sadeharju K., et al. Maternal antibodies in breast milk protect the child from enterovirus infections. Pediatrics 2007, 119:941-946.
547. Cherry J.D. Enteroviruses: polioviruses (poliomyelitis), coxsackieviruses, echoviruses, and enteroviruses. Textbook of Pediatric Infectious Diseases 1987, 1729-1790. Saunders, Philadelphia. second ed. R.D. Feigin, J.D. Cherry (Eds.).
548. Isaacs D., et al. Conservative management of an echovirus 11 outbreak in a neonatal unit. Lancet 1989, 1:543.